Hims vs Ro for GLP-1: Which Is Better? (Neither, Here's Why)

Hims vs Ro: Head-to-Head Comparison Table

Pricing Deep Dive: What You Actually Pay

Price is often the deciding factor for patients choosing between GLP-1 providers, and this is where the Hims versus Ro comparison gets nuanced. Both platforms bill a membership fee separately from medication, which can make direct comparison tricky. The headline price you see in advertising may not reflect what you actually pay once you factor in dosage tiers, commitment requirements, and ancillary fees.

In its March 2026 announcement, Hims listed its Weight Loss Membership at $39 for the first month, then auto-renewing at $149 per month, billed separately from medication, and said medication is not available without a membership. We could not confirm Hims' per-medication prices in October 2026, so check Hims' current weight-loss pricing page for medication costs.

Ro bills its membership separately from medication. Check Ro's current pricing page or our Ro pricing guide for current costs.

The real cost comparison should account for total spend over a typical treatment course of 6 to 12 months. Meanwhile, Trimi's transparent pricing model eliminates much of this complexity, a single monthly price that includes medication, consultations, and support regardless of dose tier.

Where Hims Has the Edge Over Ro

In a fair comparison, Hims does hold advantages in several areas that may matter to certain patients.

Where Ro Has the Edge Over Hims

Ro brings its own set of strengths that differentiate it from Hims, particularly for patients who prioritize clinical depth over flashy marketing.

Where Both Hims and Ro Fall Short

Despite their respective strengths, Hims and Ro share fundamental limitations that stem from their generalist business models. These are not criticisms unique to either platform, they are structural issues that affect any multi-category telehealth company trying to compete in a specialized medical niche.

Medication Quality and Pharmacy Standards

One concern that comes up frequently in Hims versus Ro discussions is medication quality. In 2026 announcements, both Hims and Ro described their weight-loss offerings in terms of FDA-approved brand-name GLP-1s such as Wegovy, while compounded GLP-1s, including Trimi's, are prepared per prescription by state-licensed pharmacies and are not FDA-approved.

The reality is that compounded medications are subject to the same regulatory framework regardless of which telehealth platform prescribes them. Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act set the federal conditions for compounding. Reputable compounding pharmacies must be licensed by their state and are overseen by state boards of pharmacy.

That said, not all compounding pharmacies are equal. The quality of a compounding pharmacy depends on its accreditation status, quality testing protocols, and track record. Patients should ask any GLP-1 provider about their pharmacy partners, whether those pharmacies hold PCAB accreditation, and what quality testing is performed on each batch. This question applies to any provider that prescribes compounded medication. For more on this topic, see our guide on compounding pharmacy regulations.

Patient Support and Clinical Follow-Up

Both Hims and Ro offer messaging-based support where patients can contact providers with questions or concerns. Response times vary, and the quality of interaction depends largely on which individual provider is assigned to your case.

Who Should Choose Hims

Hims is the right choice for patients who already use the platform for other health services and value the convenience of a single health ecosystem. Patients who are comfortable with a self-directed treatment experience and do not need extensive clinical hand-holding may also find Hims sufficient.

Who Should Choose Ro

Check Ro's current program details if consultation format or clinical support is important to your choice.

Who Should Consider Trimi Instead

Patients whose primary health goal is weight loss and who want a provider that matches that focus should seriously consider Trimi. If transparent, predictable pricing matters more to you than promotional introductory rates, if a month-to-month option is a priority, or if you want providers who specialize specifically in GLP-1 therapy and metabolic health, Trimi addresses all of these preferences. The pricing page provides full transparency on costs with no hidden fees.

Bottom Line

The Hims versus Ro comparison is a close call because both platforms offer similar services with similar limitations. Neither is a bad choice, both are legitimate companies delivering real medications prescribed by licensed providers. But framing the decision as a binary choice between two generalist platforms ignores a growing segment of specialized providers that may be a better fit for weight loss patients specifically.

Before committing to either Hims or Ro, compare both against at least one specialized alternative. Look at total cost over 6 to 12 months, evaluate the depth of clinical support, check delivery timelines, and read patient reviews focused specifically on weight loss outcomes. Your decision should be based on which provider gives you the best chance of long-term success, not which one has the biggest advertising budget.